Videos
ER+/HER2-Breast Cancer with Adam Brufsky, MD, PhD and Kimberly Blackwell, MD
Michael Manns, MD, explains the possible link between hepatitis C and hepatocellular carcinoma.
Anne Covey, MD, discusses options for patients with hepatocellular carcinoma (HCC) who cannot undergo resection or transplant.
Louis B. Harrison, discusses the recent opportunities to combine radiation therapy and immunotherapy.
Mahmoud Al-Hawary, MD, discusses the current NCCN guidelines for imaging and how they play a role in patients with pancreatic cancer.
Tuya Pal, MD, discusses the importance of genetic risk assessment shaping management guidelines in ovarian cancer.
Jeffrey Jones, MD, discusses treatment options for patients with chronic lymphocytic leukemia (CLL) who progress on, or become intolerant of, idelalisib or ibrutinib during their treatment.
Eytan Stein, MD, discusses targeting multiple mutations in patients with acute myeloid leukemia (AML).
John Leonard, MD, discusses the number of options doctors have to choose from when treating follicular lymphomas.
Differential Diagnosis
Sagar Lonial, MD, discusses an ongoing phase III trial investigating if any interventions would change the natural history of smoldering myeloma.